Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
Standard & Poors 500
NYSE COMPOSITE INDX
Gold
Crude Oil
Acorda Therapeutics, Inc.
(NQ:
ACOR
)
32.16
USD
-0.78 (-2.37%)
Official Closing Price
/ Updated:
8:10 PM EDT, May 20, 2013
/
Add to My Watchlist
View:
Quote
Overview
Detailed Quote
Charting
Options
Historical Prices
News
All News
Press Releases
Related Stories
Blogs
Podcasts
Research
Quarterly Reports
Insider Filings
Other Filings
Press releases about Acorda Therapeutics, Inc.
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Acorda Therapeutics to Host Conference Call to Report First Quarter 2007 Financial Results on May 10, 2007
May 03, 2007
from
Business Wire News Releases
Acorda Therapeutics Presents Data from its Phase 3 Study of Fampridine-SR in Multiple Sclerosis at the American Academy of Neurology Meeting
May 02, 2007
from
Business Wire News Releases
Acorda Therapeutics to Host Analyst and Investor Reception
April 25, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at 7th Annual Fortis Biotech Conference
April 18, 2007
from
Business Wire News Releases
Zacks Bull and Bear of the Day Highlights: Amphenol Corporation, Acorda Therapeutics, Synopsys and Tractor Supply
April 13, 2007
from
Business Wire News Releases
Zacks #1 Rank Top Performers: Jones Soda, U.S. Physical Therapy, Acorda Therapeutics, Crocs and DryShips
April 10, 2007
from
Business Wire News Releases
Acorda Therapeutics Presentation of Fampridine-SR Phase 3 Data Selected for Scientific Highlights Program at the American Academy of Neurology Meeting
March 19, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at the Cowen and Company 27th Annual Healthcare Conference
March 06, 2007
from
Business Wire News Releases
Acorda Therapeutics Responds to Third Point Letter
February 23, 2007
from
Business Wire News Releases
Third Point Calls for Board to Sell Acorda Therapeutics, Inc.
February 22, 2007
from
PR Newswire
Zacks Bull and Bear of the Day Highlights: Maxim Integrated, BJ's Wholesale Club, Acorda Therapeutics and Cray, Inc.
February 22, 2007
from
Business Wire News Releases
Acorda Therapeutics Reports Fourth Quarter and Full Year 2006 Financial Results
February 20, 2007
from
Business Wire News Releases
Acorda Therapeutics to Host Conference Call to Report Fourth Quarter and Year End 2006 Financial Results on February 20, 2007
February 13, 2007
from
Business Wire News Releases
Acorda Therapeutics Elects Barry Greene, COO of Alnylam, to its Board of Directors
January 08, 2007
from
Business Wire News Releases
Acorda Therapeutics Announces Completion of Zanaflex Capsules(TM) Sales Force Expansion
January 08, 2007
from
Business Wire News Releases
Acorda Therapeutics to Present at the 25th Annual JP Morgan Healthcare Conference
January 03, 2007
from
Business Wire News Releases
Hot Stocks to Watch for Friday, December 08, 2006: New Product, Millions in New Revenue!
December 08, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by Peter Antipatis of Capital Research Group Inc.
Read More
from
Marketwired News Releases
Acorda Therapeutics Provides Update on Clinical Development of Fampridine-SR
December 08, 2006
from
Business Wire News Releases
Acorda Therapeutics to Present at the BMO Capital Markets Sixth Annual Investor Conference
December 01, 2006
from
Business Wire News Releases
Acorda Therapeutics(R) to Receive Up to $10 Million from Paul Capital Healthcare
November 29, 2006
from
Business Wire News Releases
Acorda Therapeutics to Present at the 18th Annual Piper Jaffray Health Care Conference
November 21, 2006
from
Business Wire News Releases
GrowthStockAnalyst.com Spotlights $3.00 Price Target for URXE Issued by Bridge IR
November 21, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit.
Read More
from
Marketwired News Releases
(OTC PK: AXTG) Gets National Park Service Installation
November 20, 2006
NOTE TO EDITORS: The Following Is an Investment Opinion Being Issued by the IO Circuit.
Read More
from
Marketwired News Releases
Acorda Therapeutics to Present at the Lazard Capital Markets Third Annual Life Sciences Conference
November 20, 2006
from
Business Wire News Releases
Acorda Therapeutics Added to NASDAQ Biotechnology Index
November 15, 2006
from
Business Wire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
November 10, 2006
from
GlobeNewswire News Releases
Semi-Annual Changes to the NASDAQ Biotechnology Index
November 10, 2006
from
GlobeNewswire News Releases
Acorda Therapeutics Reports Third Quarter 2006 Financial Results
November 02, 2006
from
Business Wire News Releases
Acorda Therapeutics to Present at the Cowen and Company 7th Annual Health Care Conference
November 01, 2006
from
Business Wire News Releases
Acorda Therapeutics to Present at the Rodman & Renshaw 8th Annual Healthcare Conference
October 30, 2006
from
Business Wire News Releases
< Previous
1
2
...
4
5
6
7
8
9
10
11
Next >
Stock Market XML and JSON Data API
provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays.
Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.
Press Release Service
provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates
Bots go here